Loading organizations...
§ Venture Capital · 1 Rue Isaac Newton, L-2242 Luxembourg
Luxembourg-based special purpose investment vehicle holding venture capital investments in early-stage health services companies.
ACME Investments SPF Sarl is a private investment vehicle deploying capital into companies across healthcare, pharmaceutical, and software sectors. It functions as an indirect investor, acquiring stakes in publicly traded companies and participating in private placements. The entity strategically allocates funds to foster innovation and advance technologies within its focus industries.
Established and wholly controlled by Timo Syrjälä, ACME Investments SPF Sarl serves as his principal investment vehicle. Mr. Syrjälä uses this structure to strategically deploy capital, often taking significant positions in portfolio companies. The entity's formation reflects an insight into direct, focused investment within high-growth sectors, enabling nimble capital allocation.
Companies benefiting from ACME Investments SPF Sarl's capital are growth-stage enterprises in life sciences and technology. The firm’s long-term vision centers on cultivating robust portfolios by identifying and supporting businesses poised for substantial development. This strategy contributes to advancements in critical sectors while generating returns through strategic, long-term shareholdings.
ACME Investments SPF Sarl has 1 tracked investment across 1 company. The latest tracked deal is $23.6M Other Equity in TILT Biotherapeutics in February 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 7, 2023 | TILT Biotherapeutics | $23.6M Other Equity | Timo Ahopelto | Hermann Hauser, Stephen Industries |